High Risk and Very High Risk MDS
1 clinical trials · Condition
◉ Watch High Risk and Very High Risk MDS
| Record | Firm | Date |
|---|---|---|
| A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors (NCT01449058) | Array BioPharma | 2012-03-01 |
Track High Risk and Very High Risk MDS automatically
Every clearance here is in the API, with alerts when new ones post.